INSPIRE VETERINARY PARTNER Stock Price, News & Analysis

Inspire Veterinary Partners (NASDAQ: IVP) has announced its participation in the upcoming D. Boral Capital Inaugural Global Conference. The event will be held on May 14, 2025, at The Plaza Hotel in New York City. The company's President & CEO, Kimbal Carr, will be available for one-on-one meetings with interested parties from 9:00 A.M. to 3:00 P.M. (ET). Those interested in scheduling meetings can contact John Perez at jperez@dboralcapital.com.

Inspire Veterinary Partners has announced significant growth in veterinary hiring and leadership changes. The company reported a 500% increase in Doctor of Veterinary Medicine hiring for year-to-date 2025 compared to 2024.

Key developments include the appointment of Lynley Kees as Chief People Officer (CPO), effective April 28, 2025. Kees, who previously served as Vice President of Human Resources since January 2023, will oversee talent management, career development, and organizational design.

Under the leadership of Director of Recruiting Holly Hazzan and VP of Medical Operations Dr. Alex Quarti, the company has implemented new talent outreach strategies and staffed several clinics with experienced medical leaders. The company offers flexible schedule models and industry-leading benefits to support their veterinary teams in providing high-quality pet care.

Inspire Veterinary Partners (Nasdaq: IVP), a national pet healthcare services provider, has announced its participation in upcoming investor events. The company will engage in both one-on-one and group investor meetings at two key conferences:

• D. Boral Capital Global Conference in New York on May 14, 2025
• Sidoti Micro-Cap Investor Conference, a virtual event scheduled for May 21-22, 2025

Inspire Veterinary Partners (Nasdaq:IVP) reported its full year 2024 financial results, showing flat total revenue of $16.6 million. The company saw a 3% increase in services revenue to $12.2 million, while product revenue declined 8% to $4.4 million.

Operating expenses increased 7% due to the Valley Veterinary practice acquisition and consulting contracts. The net loss decreased by 4% to $14 million. The company ended 2024 with $0.5 million in cash and subsequently secured $2.0 million through a registered direct offering in March 2025, with potential for additional $4.0 million from warrant exercises.

Post-2024 developments include new leadership appointments, engagement with STNL Advisors for real estate strategy, and a non-binding LOI to acquire a Florida animal hospital potentially adding $1.8 million in revenue.

Inspire Veterinary Partners (NASDAQ:IVP), a U.S. pet healthcare services provider, has closed a registered direct offering priced at-the-market, raising $2.0 million in gross proceeds. The offering includes 1,092,896 shares of common stock (or pre-funded warrants), along with Series A and B warrants to purchase additional shares.

The purchase price is set at $1.83 per share with accompanying warrants. The Series A warrants have a 5-year term while Series B warrants expire in 18 months, both exercisable after stockholder approval. An additional $4.0 million could be raised if all warrants are exercised, though there's no guarantee of exercise.

The company plans to use the net proceeds for working capital, general corporate purposes, strategic investments, and potential future acquisitions. D. Boral Capital served as the exclusive placement agent for this offering.

Inspire Veterinary Partners (NASDAQ:IVP), a U.S. pet healthcare services provider, has announced a registered direct offering expected to close around March 26, 2025. The company will raise $2.0 million through the sale of 1,092,896 shares of common stock (or pre-funded warrants) at $1.83 per share, along with Series A and B warrants.

The offering includes Series A warrants exercisable for 5 years and Series B warrants exercisable for 18 months from the Stockholder Approval Date, potentially providing an additional $4.0 million if fully exercised. D. Boral Capital is serving as the exclusive placement agent, with The Crone Law Group, PC and Sichenzia Ross Ference Carmel LLP providing legal counsel.

Inspire Veterinary Partners (Nasdaq:IVP) has signed a non-binding letter of intent to acquire a central Florida-based animal hospital. The proposed acquisition could:

• Add approximately $1.8 million in unaudited revenue
• Increase IVP's Florida locations to 5
• Bring total network hospitals to 14

The multi-doctor general practice offers comprehensive companion animal services, including surgical procedures, dental care, and wellness care. The transaction is expected to close in Q2 2025, subject to due diligence and a definitive agreement. The acquisition aligns with Inspire's growth strategy in the Florida veterinary market, where they currently operate four animal hospitals.

Inspire Veterinary Partners (Nasdaq:IVP) has registered the trade name 'Family Pet Care' in Maryland as part of its expansion plans in the Mid-Atlantic region.

The company aims to replicate the design of its state-of-the-art Family Pet Care facility in Sugarland, Texas, across new and existing locations. This modern clinic framework focuses on providing high-quality pet care and comfort for clients and their pets.

Kimball Carr, President & CEO of Inspire, stated that the Sugarland facility was purpose-built around the needs of the care team and clients, incorporating veterinary teams' guidance into its design. Inspire looks forward to further growth in the Mid-Atlantic region and plans to announce new facilities in the future.